Francesca D'avanzo

Novara, 28100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Updating the Role of Carboplatin Added to Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis.

Updating the Role of Carboplatin Added to Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis.

Journal: Cancers
Published: November 11, 2025

Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management.

Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management.

Journal: Cancers
Published: July 10, 2025

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 15, 2023

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 20, 2023

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 31, 2023

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.

Journal: The Lancet. Oncology
Published: November 02, 2022

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.

Journal: Therapeutic advances in medical oncology
Published: May 23, 2021

Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.

Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.

Journal: Biomolecules
Published: December 29, 2020

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.

Journal: Cancers
Published: June 29, 2020

Oncolytic virotherapy: new weapon for breast cancer treatment.

Oncolytic virotherapy: new weapon for breast cancer treatment.

Journal: Ecancermedicalscience
Published: June 11, 2020

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

Journal: Cancer discovery
Published: May 29, 2020

Breast Cancer Survivorship, Quality of Life, and Late Toxicities.

Breast Cancer Survivorship, Quality of Life, and Late Toxicities.

Journal: Frontiers in oncology
Published: December 12, 2019
Showing 1-12 of 18

Last Updated: 09/26/2026